nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—KCNQ1—neck—thyroid cancer	0.0161	0.112	CbGeAlD
Indapamide—KCNE1—head—thyroid cancer	0.0148	0.103	CbGeAlD
Indapamide—KCNQ1—saliva-secreting gland—thyroid cancer	0.0125	0.0873	CbGeAlD
Indapamide—CA7—trachea—thyroid cancer	0.0106	0.0739	CbGeAlD
Indapamide—KCNQ1—thyroid gland—thyroid cancer	0.00765	0.0533	CbGeAlD
Indapamide—CA4—neck—thyroid cancer	0.0071	0.0494	CbGeAlD
Indapamide—CA12—trachea—thyroid cancer	0.0069	0.048	CbGeAlD
Indapamide—KCNQ1—head—thyroid cancer	0.00679	0.0473	CbGeAlD
Indapamide—CA2—neck—thyroid cancer	0.00589	0.041	CbGeAlD
Indapamide—CA4—saliva-secreting gland—thyroid cancer	0.00554	0.0386	CbGeAlD
Indapamide—CA5B—thyroid gland—thyroid cancer	0.00489	0.0341	CbGeAlD
Indapamide—CA12—head—thyroid cancer	0.00484	0.0337	CbGeAlD
Indapamide—KCNQ1—lymph node—thyroid cancer	0.00475	0.0331	CbGeAlD
Indapamide—CA2—saliva-secreting gland—thyroid cancer	0.00459	0.032	CbGeAlD
Indapamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EPO—thyroid cancer	0.00452	0.113	CbGpPWpGaD
Indapamide—CA5B—head—thyroid cancer	0.00434	0.0302	CbGeAlD
Indapamide—CA4—trachea—thyroid cancer	0.00427	0.0297	CbGeAlD
Indapamide—CA2—trachea—thyroid cancer	0.00354	0.0247	CbGeAlD
Indapamide—CA4—thyroid gland—thyroid cancer	0.00338	0.0235	CbGeAlD
Indapamide—CA5B—lymph node—thyroid cancer	0.00304	0.0212	CbGeAlD
Indapamide—CA4—head—thyroid cancer	0.003	0.0209	CbGeAlD
Indapamide—CA2—thyroid gland—thyroid cancer	0.0028	0.0195	CbGeAlD
Indapamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—HIF1A—thyroid cancer	0.00269	0.0675	CbGpPWpGaD
Indapamide—CA2—head—thyroid cancer	0.00249	0.0173	CbGeAlD
Indapamide—CA4—lymph node—thyroid cancer	0.0021	0.0146	CbGeAlD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—RET—thyroid cancer	0.00203	0.0509	CbGpPWpGaD
Indapamide—CA9—Cellular response to hypoxia—EPO—thyroid cancer	0.00199	0.0501	CbGpPWpGaD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—THRB—thyroid cancer	0.00188	0.0473	CbGpPWpGaD
Indapamide—CA2—lymph node—thyroid cancer	0.00174	0.0121	CbGeAlD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—PRKAR1A—thyroid cancer	0.00125	0.0314	CbGpPWpGaD
Indapamide—CA9—Cellular response to hypoxia—HIF1A—thyroid cancer	0.00119	0.0298	CbGpPWpGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.00117	0.0294	CbGpPWpGaD
Indapamide—Body temperature increased—Sorafenib—thyroid cancer	0.00113	0.00138	CcSEcCtD
Indapamide—Abdominal pain—Sorafenib—thyroid cancer	0.00113	0.00138	CcSEcCtD
Indapamide—Dermatitis bullous—Epirubicin—thyroid cancer	0.00112	0.00137	CcSEcCtD
Indapamide—Purpura—Epirubicin—thyroid cancer	0.00111	0.00136	CcSEcCtD
Indapamide—Vascular purpura—Doxorubicin—thyroid cancer	0.00111	0.00136	CcSEcCtD
Indapamide—Hepatic failure—Doxorubicin—thyroid cancer	0.0011	0.00135	CcSEcCtD
Indapamide—Cerebrovascular accident—Epirubicin—thyroid cancer	0.00109	0.00134	CcSEcCtD
Indapamide—Lethargy—Epirubicin—thyroid cancer	0.00109	0.00134	CcSEcCtD
Indapamide—Hyponatraemia—Epirubicin—thyroid cancer	0.00108	0.00132	CcSEcCtD
Indapamide—Osteoarthritis—Epirubicin—thyroid cancer	0.00107	0.00131	CcSEcCtD
Indapamide—Increased appetite—Doxorubicin—thyroid cancer	0.00105	0.00129	CcSEcCtD
Indapamide—Migraine—Epirubicin—thyroid cancer	0.00105	0.00129	CcSEcCtD
Indapamide—Dermatitis exfoliative—Doxorubicin—thyroid cancer	0.00105	0.00129	CcSEcCtD
Indapamide—Hypersensitivity—Sorafenib—thyroid cancer	0.00105	0.00129	CcSEcCtD
Indapamide—Dermatitis bullous—Doxorubicin—thyroid cancer	0.00104	0.00127	CcSEcCtD
Indapamide—Face oedema—Epirubicin—thyroid cancer	0.00103	0.00127	CcSEcCtD
Indapamide—Purpura—Doxorubicin—thyroid cancer	0.00103	0.00126	CcSEcCtD
Indapamide—Asthenia—Sorafenib—thyroid cancer	0.00102	0.00125	CcSEcCtD
Indapamide—Lethargy—Doxorubicin—thyroid cancer	0.00101	0.00124	CcSEcCtD
Indapamide—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00101	0.00124	CcSEcCtD
Indapamide—Pruritus—Sorafenib—thyroid cancer	0.00101	0.00123	CcSEcCtD
Indapamide—Ataxia—Epirubicin—thyroid cancer	0.00101	0.00123	CcSEcCtD
Indapamide—Dehydration—Epirubicin—thyroid cancer	0.000996	0.00122	CcSEcCtD
Indapamide—Hyponatraemia—Doxorubicin—thyroid cancer	0.000995	0.00122	CcSEcCtD
Indapamide—Osteoarthritis—Doxorubicin—thyroid cancer	0.000991	0.00121	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000989	0.0249	CbGpPWpGaD
Indapamide—Liver function test abnormal—Epirubicin—thyroid cancer	0.000989	0.00121	CcSEcCtD
Indapamide—Abdominal pain upper—Epirubicin—thyroid cancer	0.000978	0.0012	CcSEcCtD
Indapamide—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000978	0.0012	CcSEcCtD
Indapamide—Migraine—Doxorubicin—thyroid cancer	0.000975	0.00119	CcSEcCtD
Indapamide—Hypokalaemia—Epirubicin—thyroid cancer	0.000975	0.00119	CcSEcCtD
Indapamide—Diarrhoea—Sorafenib—thyroid cancer	0.000975	0.00119	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000964	0.00118	CcSEcCtD
Indapamide—Nasopharyngitis—Epirubicin—thyroid cancer	0.000958	0.00117	CcSEcCtD
Indapamide—Face oedema—Doxorubicin—thyroid cancer	0.000957	0.00117	CcSEcCtD
Indapamide—Gastritis—Epirubicin—thyroid cancer	0.000948	0.00116	CcSEcCtD
Indapamide—Muscular weakness—Epirubicin—thyroid cancer	0.000945	0.00116	CcSEcCtD
Indapamide—Dizziness—Sorafenib—thyroid cancer	0.000942	0.00115	CcSEcCtD
Indapamide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—thyroid cancer	0.000938	0.0236	CbGpPWpGaD
Indapamide—Ataxia—Doxorubicin—thyroid cancer	0.000932	0.00114	CcSEcCtD
Indapamide—Influenza—Epirubicin—thyroid cancer	0.000926	0.00113	CcSEcCtD
Indapamide—Asthma—Epirubicin—thyroid cancer	0.000926	0.00113	CcSEcCtD
Indapamide—Dysphagia—Epirubicin—thyroid cancer	0.000926	0.00113	CcSEcCtD
Indapamide—Dehydration—Doxorubicin—thyroid cancer	0.000922	0.00113	CcSEcCtD
Indapamide—CA9—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000917	0.023	CbGpPWpGaD
Indapamide—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000915	0.00112	CcSEcCtD
Indapamide—Pancreatitis—Epirubicin—thyroid cancer	0.000908	0.00111	CcSEcCtD
Indapamide—Vomiting—Sorafenib—thyroid cancer	0.000906	0.00111	CcSEcCtD
Indapamide—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000905	0.00111	CcSEcCtD
Indapamide—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000905	0.00111	CcSEcCtD
Indapamide—Hypokalaemia—Doxorubicin—thyroid cancer	0.000902	0.0011	CcSEcCtD
Indapamide—Angina pectoris—Epirubicin—thyroid cancer	0.000902	0.0011	CcSEcCtD
Indapamide—Rash—Sorafenib—thyroid cancer	0.000898	0.0011	CcSEcCtD
Indapamide—Dermatitis—Sorafenib—thyroid cancer	0.000897	0.0011	CcSEcCtD
Indapamide—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000892	0.00109	CcSEcCtD
Indapamide—Headache—Sorafenib—thyroid cancer	0.000892	0.00109	CcSEcCtD
Indapamide—Bronchitis—Epirubicin—thyroid cancer	0.00089	0.00109	CcSEcCtD
Indapamide—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000886	0.00109	CcSEcCtD
Indapamide—Gastritis—Doxorubicin—thyroid cancer	0.000877	0.00107	CcSEcCtD
Indapamide—Muscular weakness—Doxorubicin—thyroid cancer	0.000874	0.00107	CcSEcCtD
Indapamide—Dysuria—Epirubicin—thyroid cancer	0.000866	0.00106	CcSEcCtD
Indapamide—Asthma—Doxorubicin—thyroid cancer	0.000857	0.00105	CcSEcCtD
Indapamide—Influenza—Doxorubicin—thyroid cancer	0.000857	0.00105	CcSEcCtD
Indapamide—Dysphagia—Doxorubicin—thyroid cancer	0.000857	0.00105	CcSEcCtD
Indapamide—Pollakiuria—Epirubicin—thyroid cancer	0.000855	0.00105	CcSEcCtD
Indapamide—Nausea—Sorafenib—thyroid cancer	0.000846	0.00104	CcSEcCtD
Indapamide—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000845	0.00103	CcSEcCtD
Indapamide—Pancreatitis—Doxorubicin—thyroid cancer	0.00084	0.00103	CcSEcCtD
Indapamide—Weight decreased—Epirubicin—thyroid cancer	0.000837	0.00103	CcSEcCtD
Indapamide—Hyperglycaemia—Epirubicin—thyroid cancer	0.000835	0.00102	CcSEcCtD
Indapamide—Angina pectoris—Doxorubicin—thyroid cancer	0.000834	0.00102	CcSEcCtD
Indapamide—Pneumonia—Epirubicin—thyroid cancer	0.00083	0.00102	CcSEcCtD
Indapamide—Drowsiness—Epirubicin—thyroid cancer	0.000825	0.00101	CcSEcCtD
Indapamide—Bronchitis—Doxorubicin—thyroid cancer	0.000824	0.00101	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000818	0.001	CcSEcCtD
Indapamide—Renal failure—Epirubicin—thyroid cancer	0.000811	0.000994	CcSEcCtD
Indapamide—Stomatitis—Epirubicin—thyroid cancer	0.000805	0.000985	CcSEcCtD
Indapamide—Jaundice—Epirubicin—thyroid cancer	0.000805	0.000985	CcSEcCtD
Indapamide—Urinary tract infection—Epirubicin—thyroid cancer	0.000802	0.000982	CcSEcCtD
Indapamide—Conjunctivitis—Epirubicin—thyroid cancer	0.000802	0.000982	CcSEcCtD
Indapamide—Dysuria—Doxorubicin—thyroid cancer	0.000801	0.000981	CcSEcCtD
Indapamide—Sweating—Epirubicin—thyroid cancer	0.000791	0.000969	CcSEcCtD
Indapamide—Pollakiuria—Doxorubicin—thyroid cancer	0.000791	0.000969	CcSEcCtD
Indapamide—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000782	0.000957	CcSEcCtD
Indapamide—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000781	0.000956	CcSEcCtD
Indapamide—Weight decreased—Doxorubicin—thyroid cancer	0.000775	0.000949	CcSEcCtD
Indapamide—Sinusitis—Epirubicin—thyroid cancer	0.000774	0.000948	CcSEcCtD
Indapamide—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000773	0.000946	CcSEcCtD
Indapamide—Agranulocytosis—Epirubicin—thyroid cancer	0.00077	0.000943	CcSEcCtD
Indapamide—Pneumonia—Doxorubicin—thyroid cancer	0.000768	0.000941	CcSEcCtD
Indapamide—Drowsiness—Doxorubicin—thyroid cancer	0.000764	0.000935	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000757	0.000927	CcSEcCtD
Indapamide—Renal failure—Doxorubicin—thyroid cancer	0.000751	0.000919	CcSEcCtD
Indapamide—Jaundice—Doxorubicin—thyroid cancer	0.000744	0.000912	CcSEcCtD
Indapamide—Stomatitis—Doxorubicin—thyroid cancer	0.000744	0.000912	CcSEcCtD
Indapamide—Rhinitis—Epirubicin—thyroid cancer	0.000743	0.00091	CcSEcCtD
Indapamide—Urinary tract infection—Doxorubicin—thyroid cancer	0.000742	0.000909	CcSEcCtD
Indapamide—Conjunctivitis—Doxorubicin—thyroid cancer	0.000742	0.000909	CcSEcCtD
Indapamide—Hepatitis—Epirubicin—thyroid cancer	0.000741	0.000907	CcSEcCtD
Indapamide—Hypoaesthesia—Epirubicin—thyroid cancer	0.000737	0.000903	CcSEcCtD
Indapamide—Pharyngitis—Epirubicin—thyroid cancer	0.000735	0.000901	CcSEcCtD
Indapamide—Sweating—Doxorubicin—thyroid cancer	0.000732	0.000897	CcSEcCtD
Indapamide—Urinary tract disorder—Epirubicin—thyroid cancer	0.000732	0.000896	CcSEcCtD
Indapamide—Oedema peripheral—Epirubicin—thyroid cancer	0.00073	0.000894	CcSEcCtD
Indapamide—Urethral disorder—Epirubicin—thyroid cancer	0.000726	0.000889	CcSEcCtD
Indapamide—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000722	0.000884	CcSEcCtD
Indapamide—Sinusitis—Doxorubicin—thyroid cancer	0.000716	0.000877	CcSEcCtD
Indapamide—Visual impairment—Epirubicin—thyroid cancer	0.000714	0.000874	CcSEcCtD
Indapamide—Agranulocytosis—Doxorubicin—thyroid cancer	0.000713	0.000873	CcSEcCtD
Indapamide—Erythema multiforme—Epirubicin—thyroid cancer	0.000701	0.000858	CcSEcCtD
Indapamide—Tinnitus—Epirubicin—thyroid cancer	0.000691	0.000846	CcSEcCtD
Indapamide—Cardiac disorder—Epirubicin—thyroid cancer	0.000688	0.000842	CcSEcCtD
Indapamide—Flushing—Epirubicin—thyroid cancer	0.000688	0.000842	CcSEcCtD
Indapamide—Rhinitis—Doxorubicin—thyroid cancer	0.000687	0.000842	CcSEcCtD
Indapamide—Hepatitis—Doxorubicin—thyroid cancer	0.000686	0.00084	CcSEcCtD
Indapamide—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000682	0.000835	CcSEcCtD
Indapamide—Pharyngitis—Doxorubicin—thyroid cancer	0.00068	0.000833	CcSEcCtD
Indapamide—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000677	0.000829	CcSEcCtD
Indapamide—Oedema peripheral—Doxorubicin—thyroid cancer	0.000675	0.000827	CcSEcCtD
Indapamide—Urethral disorder—Doxorubicin—thyroid cancer	0.000672	0.000823	CcSEcCtD
Indapamide—Arrhythmia—Epirubicin—thyroid cancer	0.000662	0.000811	CcSEcCtD
Indapamide—Visual impairment—Doxorubicin—thyroid cancer	0.000661	0.000809	CcSEcCtD
Indapamide—Erythema multiforme—Doxorubicin—thyroid cancer	0.000648	0.000794	CcSEcCtD
Indapamide—Malnutrition—Epirubicin—thyroid cancer	0.000645	0.00079	CcSEcCtD
Indapamide—Erythema—Epirubicin—thyroid cancer	0.000645	0.00079	CcSEcCtD
Indapamide—Tinnitus—Doxorubicin—thyroid cancer	0.000639	0.000783	CcSEcCtD
Indapamide—Flushing—Doxorubicin—thyroid cancer	0.000636	0.000779	CcSEcCtD
Indapamide—Cardiac disorder—Doxorubicin—thyroid cancer	0.000636	0.000779	CcSEcCtD
Indapamide—Flatulence—Epirubicin—thyroid cancer	0.000636	0.000778	CcSEcCtD
Indapamide—Tension—Epirubicin—thyroid cancer	0.000633	0.000775	CcSEcCtD
Indapamide—Dysgeusia—Epirubicin—thyroid cancer	0.000632	0.000773	CcSEcCtD
Indapamide—Nervousness—Epirubicin—thyroid cancer	0.000626	0.000767	CcSEcCtD
Indapamide—Back pain—Epirubicin—thyroid cancer	0.000624	0.000764	CcSEcCtD
Indapamide—Muscle spasms—Epirubicin—thyroid cancer	0.00062	0.000759	CcSEcCtD
Indapamide—Arrhythmia—Doxorubicin—thyroid cancer	0.000612	0.00075	CcSEcCtD
Indapamide—Vision blurred—Epirubicin—thyroid cancer	0.000608	0.000744	CcSEcCtD
Indapamide—Ill-defined disorder—Epirubicin—thyroid cancer	0.000598	0.000733	CcSEcCtD
Indapamide—Malnutrition—Doxorubicin—thyroid cancer	0.000597	0.000731	CcSEcCtD
Indapamide—Erythema—Doxorubicin—thyroid cancer	0.000597	0.000731	CcSEcCtD
Indapamide—Anaemia—Epirubicin—thyroid cancer	0.000596	0.00073	CcSEcCtD
Indapamide—KCNQ1—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.000594	0.0149	CbGpPWpGaD
Indapamide—Agitation—Epirubicin—thyroid cancer	0.000593	0.000726	CcSEcCtD
Indapamide—Flatulence—Doxorubicin—thyroid cancer	0.000588	0.00072	CcSEcCtD
Indapamide—Tension—Doxorubicin—thyroid cancer	0.000586	0.000717	CcSEcCtD
Indapamide—Dysgeusia—Doxorubicin—thyroid cancer	0.000584	0.000716	CcSEcCtD
Indapamide—Malaise—Epirubicin—thyroid cancer	0.000582	0.000712	CcSEcCtD
Indapamide—Nervousness—Doxorubicin—thyroid cancer	0.00058	0.00071	CcSEcCtD
Indapamide—Vertigo—Epirubicin—thyroid cancer	0.000579	0.00071	CcSEcCtD
Indapamide—Syncope—Epirubicin—thyroid cancer	0.000578	0.000708	CcSEcCtD
Indapamide—Leukopenia—Epirubicin—thyroid cancer	0.000577	0.000707	CcSEcCtD
Indapamide—Back pain—Doxorubicin—thyroid cancer	0.000577	0.000707	CcSEcCtD
Indapamide—Muscle spasms—Doxorubicin—thyroid cancer	0.000574	0.000703	CcSEcCtD
Indapamide—CA9—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000571	0.0143	CbGpPWpGaD
Indapamide—Palpitations—Epirubicin—thyroid cancer	0.00057	0.000698	CcSEcCtD
Indapamide—Loss of consciousness—Epirubicin—thyroid cancer	0.000567	0.000694	CcSEcCtD
Indapamide—Cough—Epirubicin—thyroid cancer	0.000563	0.000689	CcSEcCtD
Indapamide—Vision blurred—Doxorubicin—thyroid cancer	0.000562	0.000689	CcSEcCtD
Indapamide—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00056	0.0141	CbGpPWpGaD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.00056	0.0141	CbGpPWpGaD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.00056	0.0141	CbGpPWpGaD
Indapamide—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000554	0.000678	CcSEcCtD
Indapamide—Anaemia—Doxorubicin—thyroid cancer	0.000552	0.000675	CcSEcCtD
Indapamide—Arthralgia—Epirubicin—thyroid cancer	0.000549	0.000672	CcSEcCtD
Indapamide—Myalgia—Epirubicin—thyroid cancer	0.000549	0.000672	CcSEcCtD
Indapamide—Chest pain—Epirubicin—thyroid cancer	0.000549	0.000672	CcSEcCtD
Indapamide—Agitation—Doxorubicin—thyroid cancer	0.000548	0.000672	CcSEcCtD
Indapamide—Anxiety—Epirubicin—thyroid cancer	0.000547	0.00067	CcSEcCtD
Indapamide—CA9—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000546	0.0137	CbGpPWpGaD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000545	0.000668	CcSEcCtD
Indapamide—Discomfort—Epirubicin—thyroid cancer	0.000543	0.000664	CcSEcCtD
Indapamide—Malaise—Doxorubicin—thyroid cancer	0.000538	0.000659	CcSEcCtD
Indapamide—Dry mouth—Epirubicin—thyroid cancer	0.000537	0.000658	CcSEcCtD
Indapamide—Vertigo—Doxorubicin—thyroid cancer	0.000536	0.000657	CcSEcCtD
Indapamide—Syncope—Doxorubicin—thyroid cancer	0.000535	0.000655	CcSEcCtD
Indapamide—Leukopenia—Doxorubicin—thyroid cancer	0.000534	0.000654	CcSEcCtD
Indapamide—Palpitations—Doxorubicin—thyroid cancer	0.000527	0.000646	CcSEcCtD
Indapamide—Anaphylactic shock—Epirubicin—thyroid cancer	0.000526	0.000645	CcSEcCtD
Indapamide—Oedema—Epirubicin—thyroid cancer	0.000526	0.000645	CcSEcCtD
Indapamide—Loss of consciousness—Doxorubicin—thyroid cancer	0.000525	0.000642	CcSEcCtD
Indapamide—Infection—Epirubicin—thyroid cancer	0.000523	0.00064	CcSEcCtD
Indapamide—Cough—Doxorubicin—thyroid cancer	0.000521	0.000638	CcSEcCtD
Indapamide—Shock—Epirubicin—thyroid cancer	0.000518	0.000634	CcSEcCtD
Indapamide—Nervous system disorder—Epirubicin—thyroid cancer	0.000516	0.000632	CcSEcCtD
Indapamide—Thrombocytopenia—Epirubicin—thyroid cancer	0.000515	0.000631	CcSEcCtD
Indapamide—Tachycardia—Epirubicin—thyroid cancer	0.000514	0.000629	CcSEcCtD
Indapamide—Skin disorder—Epirubicin—thyroid cancer	0.000511	0.000626	CcSEcCtD
Indapamide—Hyperhidrosis—Epirubicin—thyroid cancer	0.000509	0.000623	CcSEcCtD
Indapamide—Chest pain—Doxorubicin—thyroid cancer	0.000508	0.000622	CcSEcCtD
Indapamide—Myalgia—Doxorubicin—thyroid cancer	0.000508	0.000622	CcSEcCtD
Indapamide—Arthralgia—Doxorubicin—thyroid cancer	0.000508	0.000622	CcSEcCtD
Indapamide—Anxiety—Doxorubicin—thyroid cancer	0.000506	0.00062	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000505	0.000618	CcSEcCtD
Indapamide—Discomfort—Doxorubicin—thyroid cancer	0.000502	0.000615	CcSEcCtD
Indapamide—Anorexia—Epirubicin—thyroid cancer	0.000502	0.000614	CcSEcCtD
Indapamide—Dry mouth—Doxorubicin—thyroid cancer	0.000497	0.000609	CcSEcCtD
Indapamide—Hypotension—Epirubicin—thyroid cancer	0.000492	0.000602	CcSEcCtD
Indapamide—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000487	0.000596	CcSEcCtD
Indapamide—Oedema—Doxorubicin—thyroid cancer	0.000487	0.000596	CcSEcCtD
Indapamide—Infection—Doxorubicin—thyroid cancer	0.000484	0.000593	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00048	0.000587	CcSEcCtD
Indapamide—Shock—Doxorubicin—thyroid cancer	0.000479	0.000587	CcSEcCtD
Indapamide—Nervous system disorder—Doxorubicin—thyroid cancer	0.000478	0.000585	CcSEcCtD
Indapamide—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000477	0.000584	CcSEcCtD
Indapamide—Insomnia—Epirubicin—thyroid cancer	0.000476	0.000583	CcSEcCtD
Indapamide—Tachycardia—Doxorubicin—thyroid cancer	0.000475	0.000582	CcSEcCtD
Indapamide—Skin disorder—Doxorubicin—thyroid cancer	0.000473	0.000579	CcSEcCtD
Indapamide—Paraesthesia—Epirubicin—thyroid cancer	0.000473	0.000579	CcSEcCtD
Indapamide—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000471	0.000577	CcSEcCtD
Indapamide—Dyspnoea—Epirubicin—thyroid cancer	0.000469	0.000575	CcSEcCtD
Indapamide—Somnolence—Epirubicin—thyroid cancer	0.000468	0.000573	CcSEcCtD
Indapamide—Anorexia—Doxorubicin—thyroid cancer	0.000464	0.000569	CcSEcCtD
Indapamide—Dyspepsia—Epirubicin—thyroid cancer	0.000463	0.000567	CcSEcCtD
Indapamide—Decreased appetite—Epirubicin—thyroid cancer	0.000458	0.00056	CcSEcCtD
Indapamide—Hypotension—Doxorubicin—thyroid cancer	0.000455	0.000557	CcSEcCtD
Indapamide—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000454	0.000557	CcSEcCtD
Indapamide—Fatigue—Epirubicin—thyroid cancer	0.000454	0.000556	CcSEcCtD
Indapamide—CA5A—Metabolism—MINPP1—thyroid cancer	0.00045	0.0113	CbGpPWpGaD
Indapamide—Pain—Epirubicin—thyroid cancer	0.00045	0.000551	CcSEcCtD
Indapamide—Constipation—Epirubicin—thyroid cancer	0.00045	0.000551	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000444	0.000543	CcSEcCtD
Indapamide—Insomnia—Doxorubicin—thyroid cancer	0.000441	0.000539	CcSEcCtD
Indapamide—Paraesthesia—Doxorubicin—thyroid cancer	0.000437	0.000536	CcSEcCtD
Indapamide—Dyspnoea—Doxorubicin—thyroid cancer	0.000434	0.000532	CcSEcCtD
Indapamide—Feeling abnormal—Epirubicin—thyroid cancer	0.000434	0.000531	CcSEcCtD
Indapamide—Somnolence—Doxorubicin—thyroid cancer	0.000433	0.00053	CcSEcCtD
Indapamide—Gastrointestinal pain—Epirubicin—thyroid cancer	0.00043	0.000527	CcSEcCtD
Indapamide—Dyspepsia—Doxorubicin—thyroid cancer	0.000429	0.000525	CcSEcCtD
Indapamide—Decreased appetite—Doxorubicin—thyroid cancer	0.000423	0.000519	CcSEcCtD
Indapamide—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000421	0.000515	CcSEcCtD
Indapamide—CA5B—Metabolism—MINPP1—thyroid cancer	0.00042	0.0106	CbGpPWpGaD
Indapamide—CA7—Metabolism—MINPP1—thyroid cancer	0.00042	0.0106	CbGpPWpGaD
Indapamide—Fatigue—Doxorubicin—thyroid cancer	0.00042	0.000514	CcSEcCtD
Indapamide—SLC12A3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000419	0.0105	CbGpPWpGaD
Indapamide—Urticaria—Epirubicin—thyroid cancer	0.000418	0.000512	CcSEcCtD
Indapamide—Pain—Doxorubicin—thyroid cancer	0.000417	0.00051	CcSEcCtD
Indapamide—Constipation—Doxorubicin—thyroid cancer	0.000417	0.00051	CcSEcCtD
Indapamide—Body temperature increased—Epirubicin—thyroid cancer	0.000416	0.00051	CcSEcCtD
Indapamide—Abdominal pain—Epirubicin—thyroid cancer	0.000416	0.00051	CcSEcCtD
Indapamide—Feeling abnormal—Doxorubicin—thyroid cancer	0.000401	0.000492	CcSEcCtD
Indapamide—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000398	0.000488	CcSEcCtD
Indapamide—CA12—Metabolism—MINPP1—thyroid cancer	0.00039	0.00979	CbGpPWpGaD
Indapamide—Hypersensitivity—Epirubicin—thyroid cancer	0.000388	0.000475	CcSEcCtD
Indapamide—Urticaria—Doxorubicin—thyroid cancer	0.000387	0.000474	CcSEcCtD
Indapamide—Abdominal pain—Doxorubicin—thyroid cancer	0.000385	0.000472	CcSEcCtD
Indapamide—Body temperature increased—Doxorubicin—thyroid cancer	0.000385	0.000472	CcSEcCtD
Indapamide—CA5A—Metabolism—NDUFA13—thyroid cancer	0.000383	0.00962	CbGpPWpGaD
Indapamide—Asthenia—Epirubicin—thyroid cancer	0.000378	0.000463	CcSEcCtD
Indapamide—Pruritus—Epirubicin—thyroid cancer	0.000372	0.000456	CcSEcCtD
Indapamide—Diarrhoea—Epirubicin—thyroid cancer	0.00036	0.000441	CcSEcCtD
Indapamide—CA5A—Metabolism—CHST14—thyroid cancer	0.00036	0.00905	CbGpPWpGaD
Indapamide—Hypersensitivity—Doxorubicin—thyroid cancer	0.000359	0.000439	CcSEcCtD
Indapamide—CA7—Metabolism—NDUFA13—thyroid cancer	0.000357	0.00898	CbGpPWpGaD
Indapamide—CA5B—Metabolism—NDUFA13—thyroid cancer	0.000357	0.00898	CbGpPWpGaD
Indapamide—Asthenia—Doxorubicin—thyroid cancer	0.000349	0.000428	CcSEcCtD
Indapamide—Dizziness—Epirubicin—thyroid cancer	0.000348	0.000426	CcSEcCtD
Indapamide—Pruritus—Doxorubicin—thyroid cancer	0.000345	0.000422	CcSEcCtD
Indapamide—CA7—Metabolism—CHST14—thyroid cancer	0.000336	0.00845	CbGpPWpGaD
Indapamide—CA5B—Metabolism—CHST14—thyroid cancer	0.000336	0.00845	CbGpPWpGaD
Indapamide—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000335	0.00842	CbGpPWpGaD
Indapamide—Vomiting—Epirubicin—thyroid cancer	0.000335	0.00041	CcSEcCtD
Indapamide—Diarrhoea—Doxorubicin—thyroid cancer	0.000333	0.000408	CcSEcCtD
Indapamide—Rash—Epirubicin—thyroid cancer	0.000332	0.000406	CcSEcCtD
Indapamide—Dermatitis—Epirubicin—thyroid cancer	0.000332	0.000406	CcSEcCtD
Indapamide—CA12—Metabolism—NDUFA13—thyroid cancer	0.000331	0.00832	CbGpPWpGaD
Indapamide—Headache—Epirubicin—thyroid cancer	0.00033	0.000404	CcSEcCtD
Indapamide—Dizziness—Doxorubicin—thyroid cancer	0.000322	0.000394	CcSEcCtD
Indapamide—Nausea—Epirubicin—thyroid cancer	0.000313	0.000383	CcSEcCtD
Indapamide—CA12—Metabolism—CHST14—thyroid cancer	0.000311	0.00783	CbGpPWpGaD
Indapamide—CA4—Metabolism—MINPP1—thyroid cancer	0.000311	0.00781	CbGpPWpGaD
Indapamide—Vomiting—Doxorubicin—thyroid cancer	0.00031	0.000379	CcSEcCtD
Indapamide—KCNQ1—Neuronal System—BRAF—thyroid cancer	0.000309	0.00776	CbGpPWpGaD
Indapamide—Rash—Doxorubicin—thyroid cancer	0.000307	0.000376	CcSEcCtD
Indapamide—Dermatitis—Doxorubicin—thyroid cancer	0.000307	0.000376	CcSEcCtD
Indapamide—Headache—Doxorubicin—thyroid cancer	0.000305	0.000374	CcSEcCtD
Indapamide—CA9—Cellular responses to stress—EPO—thyroid cancer	0.000303	0.0076	CbGpPWpGaD
Indapamide—CA2—Metabolism—MINPP1—thyroid cancer	0.000298	0.00748	CbGpPWpGaD
Indapamide—CA5A—Metabolism—HPGD—thyroid cancer	0.00029	0.00729	CbGpPWpGaD
Indapamide—Nausea—Doxorubicin—thyroid cancer	0.000289	0.000354	CcSEcCtD
Indapamide—SLC12A3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000284	0.00715	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000284	0.00715	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.00028	0.00703	CbGpPWpGaD
Indapamide—CA5B—Metabolism—HPGD—thyroid cancer	0.000271	0.00681	CbGpPWpGaD
Indapamide—CA7—Metabolism—HPGD—thyroid cancer	0.000271	0.00681	CbGpPWpGaD
Indapamide—CA4—Metabolism—NDUFA13—thyroid cancer	0.000264	0.00664	CbGpPWpGaD
Indapamide—CA2—Metabolism—NDUFA13—thyroid cancer	0.000253	0.00636	CbGpPWpGaD
Indapamide—CA12—Metabolism—HPGD—thyroid cancer	0.000251	0.00631	CbGpPWpGaD
Indapamide—CA9—Metabolism—MINPP1—thyroid cancer	0.000251	0.00631	CbGpPWpGaD
Indapamide—CA4—Metabolism—CHST14—thyroid cancer	0.000248	0.00624	CbGpPWpGaD
Indapamide—CA2—Metabolism—CHST14—thyroid cancer	0.000238	0.00598	CbGpPWpGaD
Indapamide—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000221	0.00555	CbGpPWpGaD
Indapamide—CA9—Metabolism—NDUFA13—thyroid cancer	0.000213	0.00536	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000213	0.00535	CbGpPWpGaD
Indapamide—CA9—Metabolism—CHST14—thyroid cancer	0.000201	0.00504	CbGpPWpGaD
Indapamide—CA4—Metabolism—HPGD—thyroid cancer	0.0002	0.00503	CbGpPWpGaD
Indapamide—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000195	0.0049	CbGpPWpGaD
Indapamide—CA2—Metabolism—HPGD—thyroid cancer	0.000192	0.00482	CbGpPWpGaD
Indapamide—CA9—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.000184	0.00461	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—HIF1A—thyroid cancer	0.00018	0.00453	CbGpPWpGaD
Indapamide—SLC12A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000179	0.0045	CbGpPWpGaD
Indapamide—CA5A—Metabolism—TPR—thyroid cancer	0.000167	0.00419	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PRKAR1A—thyroid cancer	0.000164	0.00412	CbGpPWpGaD
Indapamide—CA9—Metabolism—HPGD—thyroid cancer	0.000162	0.00406	CbGpPWpGaD
Indapamide—CA5B—Metabolism—TPR—thyroid cancer	0.000156	0.00391	CbGpPWpGaD
Indapamide—CA7—Metabolism—TPR—thyroid cancer	0.000156	0.00391	CbGpPWpGaD
Indapamide—CA7—Metabolism—PRKAR1A—thyroid cancer	0.000153	0.00385	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PRKAR1A—thyroid cancer	0.000153	0.00385	CbGpPWpGaD
Indapamide—CA12—Metabolism—TPR—thyroid cancer	0.000144	0.00362	CbGpPWpGaD
Indapamide—KCNQ1—Neuronal System—HRAS—thyroid cancer	0.000142	0.00357	CbGpPWpGaD
Indapamide—CA12—Metabolism—PRKAR1A—thyroid cancer	0.000142	0.00356	CbGpPWpGaD
Indapamide—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000134	0.00336	CbGpPWpGaD
Indapamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000133	0.00334	CbGpPWpGaD
Indapamide—CA5A—Metabolism—SLC5A5—thyroid cancer	0.000125	0.00314	CbGpPWpGaD
Indapamide—CA5B—Metabolism—SLC5A5—thyroid cancer	0.000116	0.00293	CbGpPWpGaD
Indapamide—CA7—Metabolism—SLC5A5—thyroid cancer	0.000116	0.00293	CbGpPWpGaD
Indapamide—CA4—Metabolism—TPR—thyroid cancer	0.000115	0.00289	CbGpPWpGaD
Indapamide—CA4—Metabolism—PRKAR1A—thyroid cancer	0.000113	0.00284	CbGpPWpGaD
Indapamide—CA2—Metabolism—TPR—thyroid cancer	0.00011	0.00277	CbGpPWpGaD
Indapamide—CA2—Metabolism—PRKAR1A—thyroid cancer	0.000108	0.00273	CbGpPWpGaD
Indapamide—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000108	0.00272	CbGpPWpGaD
Indapamide—CA12—Metabolism—SLC5A5—thyroid cancer	0.000108	0.00271	CbGpPWpGaD
Indapamide—CA5A—Metabolism—RXRA—thyroid cancer	0.000105	0.00263	CbGpPWpGaD
Indapamide—CA5B—Metabolism—RXRA—thyroid cancer	9.79e-05	0.00246	CbGpPWpGaD
Indapamide—CA7—Metabolism—RXRA—thyroid cancer	9.79e-05	0.00246	CbGpPWpGaD
Indapamide—CA9—Metabolism—TPR—thyroid cancer	9.29e-05	0.00233	CbGpPWpGaD
Indapamide—CA9—Metabolism—PRKAR1A—thyroid cancer	9.14e-05	0.0023	CbGpPWpGaD
Indapamide—CA12—Metabolism—RXRA—thyroid cancer	9.07e-05	0.00228	CbGpPWpGaD
Indapamide—CA4—Metabolism—SLC5A5—thyroid cancer	8.61e-05	0.00216	CbGpPWpGaD
Indapamide—CA2—Metabolism—SLC5A5—thyroid cancer	8.25e-05	0.00207	CbGpPWpGaD
Indapamide—CA4—Metabolism—RXRA—thyroid cancer	7.23e-05	0.00182	CbGpPWpGaD
Indapamide—CA9—Cellular responses to stress—TP53—thyroid cancer	7.17e-05	0.0018	CbGpPWpGaD
Indapamide—CA9—Metabolism—SLC5A5—thyroid cancer	6.95e-05	0.00175	CbGpPWpGaD
Indapamide—CA2—Metabolism—RXRA—thyroid cancer	6.93e-05	0.00174	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PPARG—thyroid cancer	6.62e-05	0.00166	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PPARG—thyroid cancer	6.18e-05	0.00155	CbGpPWpGaD
Indapamide—CA7—Metabolism—PPARG—thyroid cancer	6.18e-05	0.00155	CbGpPWpGaD
Indapamide—CA9—Metabolism—RXRA—thyroid cancer	5.84e-05	0.00147	CbGpPWpGaD
Indapamide—CYP3A4—Biological oxidations—RXRA—thyroid cancer	5.75e-05	0.00145	CbGpPWpGaD
Indapamide—CA12—Metabolism—PPARG—thyroid cancer	5.72e-05	0.00144	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTGS2—thyroid cancer	5.21e-05	0.00131	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTGS2—thyroid cancer	4.86e-05	0.00122	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTGS2—thyroid cancer	4.86e-05	0.00122	CbGpPWpGaD
Indapamide—CA4—Metabolism—PPARG—thyroid cancer	4.57e-05	0.00115	CbGpPWpGaD
Indapamide—CA5A—Metabolism—PTEN—thyroid cancer	4.54e-05	0.00114	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTGS2—thyroid cancer	4.5e-05	0.00113	CbGpPWpGaD
Indapamide—CA2—Metabolism—PPARG—thyroid cancer	4.38e-05	0.0011	CbGpPWpGaD
Indapamide—CA7—Metabolism—PTEN—thyroid cancer	4.24e-05	0.00107	CbGpPWpGaD
Indapamide—CA5B—Metabolism—PTEN—thyroid cancer	4.24e-05	0.00107	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.23e-05	0.00106	CbGpPWpGaD
Indapamide—CA12—Metabolism—PTEN—thyroid cancer	3.93e-05	0.000987	CbGpPWpGaD
Indapamide—CA9—Metabolism—PPARG—thyroid cancer	3.69e-05	0.000927	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.59e-05	0.000903	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTGS2—thyroid cancer	3.59e-05	0.000903	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTGS2—thyroid cancer	3.44e-05	0.000865	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—CHST14—thyroid cancer	3.38e-05	0.000849	CbGpPWpGaD
Indapamide—CA4—Metabolism—PTEN—thyroid cancer	3.13e-05	0.000787	CbGpPWpGaD
Indapamide—CA2—Metabolism—PTEN—thyroid cancer	3e-05	0.000755	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTGS2—thyroid cancer	2.9e-05	0.000729	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—HPGD—thyroid cancer	2.72e-05	0.000684	CbGpPWpGaD
Indapamide—CA5A—Metabolism—AKT1—thyroid cancer	2.62e-05	0.000658	CbGpPWpGaD
Indapamide—CA9—Metabolism—PTEN—thyroid cancer	2.53e-05	0.000636	CbGpPWpGaD
Indapamide—CA5B—Metabolism—AKT1—thyroid cancer	2.44e-05	0.000614	CbGpPWpGaD
Indapamide—CA7—Metabolism—AKT1—thyroid cancer	2.44e-05	0.000614	CbGpPWpGaD
Indapamide—CA12—Metabolism—AKT1—thyroid cancer	2.26e-05	0.000569	CbGpPWpGaD
Indapamide—CA4—Metabolism—AKT1—thyroid cancer	1.8e-05	0.000454	CbGpPWpGaD
Indapamide—CA2—Metabolism—AKT1—thyroid cancer	1.73e-05	0.000435	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—TPR—thyroid cancer	1.56e-05	0.000393	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.54e-05	0.000387	CbGpPWpGaD
Indapamide—CA9—Metabolism—AKT1—thyroid cancer	1.46e-05	0.000367	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.17e-05	0.000294	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—RXRA—thyroid cancer	9.84e-06	0.000247	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PPARG—thyroid cancer	6.21e-06	0.000156	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTGS2—thyroid cancer	4.89e-06	0.000123	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—PTEN—thyroid cancer	4.26e-06	0.000107	CbGpPWpGaD
Indapamide—CYP3A4—Metabolism—AKT1—thyroid cancer	2.46e-06	6.17e-05	CbGpPWpGaD
